FDA Approves New Treatment Option for Common and Serious Complication of Life-saving Stem Cell TransplantsPosted On: September 24, 2021
Rye Brook, N.Y., September 24, 2021 — The U.S. Read More
Rye Brook, N.Y., September 21, 2021 – A diverse group of cancer experts from leading academic institutions (UCLA, Emory University, NYU, Stanford University), the National Cancer Institute, and The Leukemia & Lymphoma Society (LLS) published recommendations for maximizing protection against COVID-19 among patients with blood cancer. The paper was published online in Blood Cancer Discovery, a journal of the American Association for Cancer Research.Read More
Rye Brook, N.Y., September 17, 2021 - The U.S. Read More
Rye Brook, N.Y., Sept. 17, 2021—The Leukemia & Lymphoma Society thanks members of the House Energy & Commerce Committee and the House Ways & Means Committee who voted to take critical steps to reduce barriers to care and increase affordability for many of the nearly 1.5 million people in the U.S. living with blood cancer. These crucial reforms will ensure more people can get the treatment they need at the moment they need it.Read More
Please send all media-related inquiries and interview requests to firstname.lastname@example.org. An LLS representative will respond as soon as possible.